Targeting a viral vulnerability to treat disease
September 18, 2018
Dr. Robert Ricciardi,Chair of Microbiology, is developing promising therapies for viral diseases. Through the Penn Center for Innovation, his company, ViRAZE, is first taking aim at a skin condition that affects millions of children.